BURNETT JOSEPH 4

What Happened

Joseph M. Burnett, CEO, President and a director of ClearPoint Neuro (CLPT), acquired 1,361 shares of the company's common stock on June 30, 2026. The shares were purchased at $11.93 per share under the company Employee Stock Purchase Plan (ESPP), for a total cost of approximately $16,237. This was a purchase (acquisition) reported on a Form 4.

Key Details

• Transaction date: 2026-06-30; reported on Form 4 filed 2026-07-02 (filed two days after the transaction, which appears timely for a Form 4).
• Price: $11.93 per share; Total reported value: $16,237.
• Shares acquired: 1,361.
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes:
  • F1: Shares bought under the ESPP for the Jan 1–Jun 30, 2026 purchase period; ESPP price = lesser of 85% of fair market value on first or last day of the period.
  • F2: Shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph Burnett as trustee.

Context

This was an ESPP purchase, meaning shares were bought at a discount (85% of the applicable fair market value), not open-market trading. ESPP purchases are common for employees and executives and reflect an internal plan purchase rather than a secondary-market investment decision. The filing shows a modest dollar amount (~$16k) and does not by itself indicate broader changes in insider ownership or strategy.